Literature DB >> 3445015

Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients.

G D'Amico1, G Colasanti, G Barbiano di Belgioioso, G Fellin, A Ragni, F Egidi, L Radaelli, G Fogazzi, C Ponticelli, L Minetti.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3445015

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN： 0270-9295            Impact factor:   5.299


× No keyword cloud information.
  17 in total

1.  IgA nephropathy presenting clinical features of poststreptococcal glomerulonephritis.

Authors:  Naila Al-Ruqeishi; Poothirikovil Venugopalan; Ibtisam El Nour; Anand Date
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

2.  Clinical assessment of low-dose steroid therapy for patients with IgA nephropathy: a prospective study in a single center.

Authors:  Minako Koike; Takashi Takei; Keiko Uchida; Kazuho Honda; Takahito Moriyama; Shigeru Horita; Tetsuya Ogawa; Takumi Yoshida; Ken Tsuchiya; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2008-02-21       Impact factor: 2.801

3.  Prognostic indicators in children with IgA nephropathy--report of the Southwest Pediatric Nephrology Study Group.

Authors:  R J Hogg; F G Silva; R J Wyatt; J S Reisch; J C Argyle; D A Savino
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

4.  Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.

Authors:  Y Wang; M-H Zhao; Y-K Zhang; X-M Li; H-Y Wang
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

5.  The Serum Uric Acid Level Is Related to the More Severe Renal Histopathology of Female IgA Nephropathy Patients.

Authors:  Won Jung Choi; Yu A Hong; Ji Won Min; Eun Sil Koh; Hyung Duk Kim; Tae Hyun Ban; Young Soo Kim; Yong Kyun Kim; Seok Joon Shin; Seok Young Kim; Young Ok Kim; Chul Woo Yang; Yoon-Kyung Chang
Journal:  J Clin Med       Date:  2021-04-27       Impact factor: 4.241

Review 6.  Steroids in the treatment of IgA nephropathy to the improvement of renal survival: a systematic review and meta-analysis.

Authors:  Yu-Hao Zhou; Li-Gong Tang; Shi-Lei Guo; Zhi-Chao Jin; Mei-Jing Wu; Jia-Jie Zang; Jin-Fang Xu; Chun-Fang Wu; Ying-Yi Qin; Qing Cai; Qing-Bin Gao; Shan-Shan Zhang; Dand-Hui Yu; Jia He
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240

7.  Predicting progression of IgA nephropathy: new clinical progression risk score.

Authors:  Jingyuan Xie; Krzysztof Kiryluk; Weiming Wang; Zhaohui Wang; Shanmai Guo; Pingyan Shen; Hong Ren; Xiaoxia Pan; Xiaonong Chen; Wen Zhang; Xiao Li; Hao Shi; Yifu Li; Ali G Gharavi; Nan Chen
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

8.  A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study.

Authors:  Masashi Goto; Kenji Wakai; Takashi Kawamura; Masahiko Ando; Masayuki Endoh; Yasuhiko Tomino
Journal:  Nephrol Dial Transplant       Date:  2009-06-10       Impact factor: 5.992

9.  Increased plasma sVCAM-1 is associated with severity in IgA nephropathy.

Authors:  Li Zhu; Sufang Shi; Lijun Liu; Jicheng Lv; Hong Zhang
Journal:  BMC Nephrol       Date:  2013-01-22       Impact factor: 2.388

10.  Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy.

Authors:  Seung Jun Kim; Hyang Mo Koo; Beom Jin Lim; Hyung Jung Oh; Dong Eun Yoo; Dong Ho Shin; Mi Jung Lee; Fa Mee Doh; Jung Tak Park; Tae-Hyun Yoo; Shin-Wook Kang; Kyu Hun Choi; Hyeon Joo Jeong; Seung Hyeok Han
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.